Bioassay of pivalolactone for possible carcinogenicity / Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health.
| Other author | National Cancer Institute (U.S.). Division of Cancer Cause and Prevention. |
| Other author | Carcinogenesis Testing Program (U.S.) |
| Other author | National Institutes of Health (U.S.) |
| Format | Electronic |
| Publication Info | Bethesda, Md. : U.S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1978. |
| Description | 1 online resource (104 unnumbered pages) : illustrations. |
| Supplemental Content | https://purl.fdlp.gov/GPO/gpo31675 |
| Subjects |
| Series | Carcinogenesis technical report series ; no. 140 DHEW publication ; no. (NIH) 78-1395 National Cancer Institute carcinogenesis technical report series ; no. 140. ^A1107162 DHEW publication no. (NIH) 78-1395. ^A204 |
| General note | Title from title screen (viewed on Nov. 29, 2012). |
| General note | "NCI-CG-TR-140." |
| General note | "CAS no. 1955-45-9 ." |
| Bibliography note | Includes bibliographical references (p. 44-45). |
| Issued in other form | Print version: National Cancer Institute (U.S.). Division of Cancer Cause and Prevention. Bioassay of pivalolactone for possible carcinogenicity |
| Technical rpt# | CAS no. 1955-45-9 |
| Technical rpt number | NCI-CG-TR-140 |
| GPO item number | 0507-G-12 (online) |
| Govt. docs number | HE 20.3159/2:140 |